DIA's Annual Canadian Meeting: New Reality / New Frontiers

Pharmacovigilance is a rapidly evolving and increasingly global field. Government and Industry are often criticised for taking action in one jurisdiction not always harmonised to action in another. With the near instantaneous dissemination of information and the different global regulatory practices with respect to risk management, the regulators and the pharmaceutical industry are faced with challenges in trying to find the best way to manage risk while at the same time meeting expectations from various stakeholders. This session will provide the perspective of Health Canada, Industry and other stakeholders to provide understanding and appreciation of the current practices, consumers’ expectations, challenges and opportunities for change. The expectations of global harmonisation will also be explored.